Biotech Stock Nearly 300% Sparks Massive Bet on 2027 Breast Drug
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Retirees benefit from selecting tax-efficient asset classes and optimized withdrawal sequencing. Learn which classes to favor and why.
23,930 articlesA biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
As tensions flare, on-chain futures venue Hyperliquid and its HYPE token surge into crypto's top tier. Traders turn t...
The FBI has issued a warning about spoof tokens targeting Tron wallets, deploying as TRC-20 assets to threaten asset ...
Verizon Communications stock soaring in 2026 has investors debating its next move. This guide breaks down the drivers...
Hyperliquid's HYPE hovers around $39 after a daily dip, but a persistent rising channel and fresh institutional acces...
Rising costs are changing what an engagement ring represents for many couples. This article explores why engagement r...
INDA still leads India ETF liquidity, but two rivals, EPI and IND, are drawing attention for their unique screens and...
Rising college costs and changing job markets are pushing families to rethink Ivy League prestige. A new wave of non-...
Veteran investor Mark Kvamme is rolling out a Temasek style OHIO Fund, a $500 million vehicle aimed at accelerating g...
PEY sits at a crossroads, pairing long-running dividend growers with higher-yielding, potentially riskier payors. As ...
JPMorgan researchers warn that ether and other altcoins could keep lagging Bitcoin without clearer growth in on-chain...
Crypto traders are pricing SpaceX ahead of any IPO using Hyperliquid's SPCX-USDC contract, with early data suggesting...